Cabaletta Bio Inc CABA

NAS: CABA | ISIN: US12674W1099   1/05/2025
1,250 USD (-5,30%)
(-5,30%)   1/05/2025
Grafiek Cabaletta Bio Inc Grafiek Cabaletta Bio Inc

Cabaletta Bio Inc in het nieuws

25 september 2023 · Thinking about buying stock in Nikola Corp, Eos Energy Enterprises, Applied Therapeutics, Tango Therapeutics, or Cabaletta Bio? · Persbericht

28 april 2022 · CABA LAWSUIT ALERT: Levi & Korsinsky Notifies Cabaletta Bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline · Persbericht

21 april 2022 · CABA LAWSUIT ALERT: Levi & Korsinsky Notifies Cabaletta Bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline · Persbericht

14 april 2022 · CABA LAWSUIT ALERT: Levi & Korsinsky Notifies Cabaletta Bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline · Persbericht

7 april 2022 · CABA LAWSUIT ALERT: Levi & Korsinsky Notifies Cabaletta Bio, Inc. Investors Of A Class Action Lawsuit And Upcoming Deadline · Persbericht

31 maart 2022 · CABA LAWSUIT ALERT: Levi & Korsinsky Notifies Cabaletta Bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline · Persbericht

24 maart 2022 · CABA LAWSUIT ALERT: Levi & Korsinsky Notifies Cabaletta Bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline · Persbericht

17 maart 2022 · CABA LAWSUIT ALERT: Levi & Korsinsky Notifies Cabaletta Bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline · Persbericht

15 maart 2022 · Investor Notice: April 29th Deadline in Lawsuit for Investors who Lost over $50,000 in Cabaletta Bio, Inc. shares announced by Shareholders Foundation · Persbericht

13 maart 2022 · UPCOMING DEADLINE: Cabaletta Bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - CABA · Persbericht

Profiel Cabaletta Bio Inc

Biotechnologie
Gezondheidstechnologie

Werknemers: 66

Mijn selecties